| Autor: |
Majumder, Md Anwarul Azim, Singh, Keerti, Johnson, WMS, Rajasundaram, Archana, Gupta, Subir, Gaur, Uma, Kumar, Santosh, Chatterjee, Madhuri, Rabbi, Ahbab Mohammad Fazle, Sangishetti, Vijay Prasad, Rahman, Sayeeda, Campbell, Michael H, Harewood, Heather, Bharatha, Ambadasu, Krishnamurthy, Kandamaran, Kabir, Russell, Parsa, Ali Davod, Mohammmad, Shegufta, Haque, Mainul, Razzaque, Mohammed S |
| Předmět: |
|
| Zdroj: |
Journal of Multidisciplinary Healthcare; Jan2023, Vol. 16, p161-174, 14p |
| Abstrakt: |
Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study investigated the prevalence, severity, and onset of side effects following the first dose of COVID-19 vaccines among physicians and dentists working in various healthcare settings across India. Methods: A cross-sectional survey collected self-report data from April to June 2021 on side effects following the first dose of the vaccine. An online validated questionnaire using the Google Docs® platform was circulated via email and social media platforms. Results: More than 40% of participants experienced at least one side effect after the first dose of vaccination; the most common were mild and resolved within three days after vaccination. More than 91% of respondents received the Covishield (AstraZeneca) vaccine; the most prevalent adverse effects were soreness of the injected arm (78.9%), tiredness (71.1%), and fever (54.9%). Logistic regression showed that women were almost 60% less likely to report side effects. Conclusion: Findings supported the safety of the first dose of the COVID-19 vaccine based on relatively few self-limiting side effects, mainly soreness of the injected arm and tiredness. Further research is needed to determine the long-term safety of COVID-19 vaccines, especially after booster doses. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
